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In defining the focus of the present Jornal de Pediatria
supplement, we tried to group treatment approaches to
problems that are commonly observed in routine pediatric
practice. Recent advances in the pharmacological context
have led to changes in the treatment of many diseases and
prompted the need for constant updates regarding the
drug arsenal made available for the management of such
conditions.
Pediatric specialties such as pulmonology and allergy
are linked by scope. They share the same clinical approach
in a number of diseases that fall within the domain of both
specialties. They also share the same treatment arsenal
and the challenge of keeping up to date with specific
pharmacological information.
New drugs resulting from advances in clinical research
no doubt deserve a dedicated supplement providing
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updated treatment information on diseases that are
common to both pulmonology and allergy. Furthermore,
this update should transcend the scope of specialties to
encompass general pediatrics.
One of the most important aspects related to clinical
pharmacology is the difficulty in establishing treatment
boundaries. As the use of certain drugs becomes more
frequent, their prescription range is constantly modified.
It is common to see new uses for old drugs, with
broader application patterns resulting from a favorable
safety profile and the pressure to produce results. The
constant updates in clinical pharmacology are a common
challenge to all of those working with patients.
In defining a scope of action that emphasizes common
clinical situations in routine pediatric practice, we are at
the same time widening the domain of specialties.
1. Professor titular e livre-docente, Disciplina de Alergia, Imunologia Clínica e Reumatologia, Departamento de Pediatria, Universidade Federal de São Paulo -
Escola Paulista de Medicina (UNIFESP-EPM), São Paulo, SP, Brasil.
2. Professor adjunto, Departamento de Pediatria, Fundação Faculdade Federal de Ciências Médicas de Porto Alegre (FFFCMPA), Porto Alegre, RS, Brasil.
Chefe, Serviço de Emergência Pediátrica, Hospital da Criança Santo Antônio, Complexo Hospitalar Santa Casa, Porto Alegre, RS, Brasil.
Suggested citation: Solé D, Amantéa SL. New perspectives in the drug management of allergy and respiratory diseases. J Pediatr (Rio J). 2006;82(5
Suppl):S125-6.
Dirceu SolØ1 SØrgio L. AmantØa2
126  Jornal de Pediatria - Vol. 82, No.5(Suppl), 2006 Drug management of allergy and respiratory diseases  SolØ D & AmantØa SL
In this supplement, the pharmacological approach to
diseases such as bronchial asthma and allergic rhinitis is
presented in more than one article, with in-depth coverage
of the specific use of several drugs (monoclonal anti-IgE
antibodies, inhaled corticosteroids, antileukotrienes and
the new antihistamines). Unique and particular aspects of
anti-infection treatment are discussed, such as antimicrobial
resistance and drug allergies. Situations that are commonly
faced in clinical practice, such as childhood dermatitis and
gastroesophageal reflux disease, are presented from a
practical treatment perspective. In addition, controversial
issues such as the real benefits of treatment with pre and
probiotics, nonsteroidal anti-inflammatory drugs (selective
COX2 inhibitors) and drugs for treatment of pediatric
pulmonary hypertension add to our challenge.
We hope that our objectives have been met, and also
that the convictions and controversies presented herein
will serve as stimulus for the search for  further
pharmacological knowledge concerning common challenges
in pediatric practice.
